OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
85 hedge funds and large institutions have $156M invested in OncoMed Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less funds holding
Funds holding: 86 → 85 (-1)
Holders
85
Holding in Top 10
1
Calls
$7.57M
Puts
$3.19M
Top Buyers
| 1 | +$15.6M | |
| 2 | +$6.27M | |
| 3 | +$2.61M | |
| 4 |
Primecap Management
Pasadena,
California
|
+$975K |
| 5 |
CC
Cannell & Co
New York
|
+$728K |
Top Sellers
| 1 | -$1.47M | |
| 2 | -$791K | |
| 3 | -$654K | |
| 4 |
IHM
Iguana Healthcare Management
New York
|
-$553K |
| 5 |
Morgan Stanley
New York
|
-$517K |